维普期刊资源整合服务平台（V6.5）

270篇 您的检索式：作者名="Olsson Ag"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	The case for intensive statin therapy aider acute coronary syndromes 显示文摘	Schwartz GG Olsson AG	2005	Am J Cardiol2005，96，5：	1
2	The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease显示文摘	Kjekshus J Pedersen TR Olsson AG	1997	J Card Fail1997，3，：	1
3	High-density lipopro- tein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome:results from the MIRACL trial显示文摘	Olsson AG Schwartz GG Szarek M	2005	Eur Heart J2005，26，9：	1
4	Impaired cortisol response to acute stressors in patients with coronary disease:Implications for inflammatory activity显示文摘	Nijm J Kristenson M Olsson AG	2007	J Intern Med2007，262，3：	1
5	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，：	1
6	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Olsson AG Ezekowitz MD	2001	JAMA2001，285，：	1
7	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1
8	Effects of high-dose atorvas-tatin in patients≥65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering study)显示文摘	Olsson AG Schwartz GG Szarek M et a1	2007	Am JCaMiol2007，99，5：	1
9	Biological mechanis for the clinical success of lipid-lowering in coronary arthry disease and the use of surrogate endpoints显示文摘	kinlay S Schwartz GG Olsson AG	1996	Curr Opin Lipidol1996，7，：	1
10	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes the MIRACL study:a randomizedcontrolled trial显示文摘	Schwartz GG Olsson Ag Ezekowitz MD	2001	JAMA2001，285，：	1
11	Lipopro-tein changes and reduction in the incidence of major coro-nary heart disease events in the Scandinavian simvastatinsurvival study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	2004	Atheroscler Suppl2004，5，3：	1
12	Effect of rosuvastatin on lowdensity lipoprotein cliolesterol in patients with hypercholesterolenria显示文摘	Olsson AG Pears J McKellar J		0，，：	1
13	Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial 显示文摘	Sullivan D Olsson AG Scott R	2012	JAMA2012，308，23：	1
14	lnflammatory bio- markers,death,and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study显示文摘	Zamani P Schwartz GG Olsson AG	2013	J Am Heart Assoc2013，282，00：	1
15	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz Md	2001	JAMA2001，285，13：	1
16	High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study 显示文摘	Kinlay S Schwartz GG Olsson AG	2003	Circulation2003，108，13：	1
17	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian simvastatin survival study (4S)显示文摘	Pedersen TR Olsson AG Farergeman O	1998	Circulation1998，97，15：	1
18	Effects of atorvastatin on early recurrent ischemia events in acute coronary syndrome,the MIRACL study,A randomised clinical trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，3：	1
19	Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: The GAUSS randomized trial 显示文摘	Sullivan D Olsson AG Scott R	2012	JAMA2012，308，23：	1
20	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial显示文摘	Schwartz GG Olsson AG Ezekowitz MD	2001	JAMA2001，285，13：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示